Orchasp Ltd leads losers in 'B' group

Orchasp Ltd leads losers in 'B' group


Hindustan Oil Exploration Company Ltd, Dhruv Consultancy Services Ltd, Antelopus Selan Energy Ltd and JHS Svendgaard Retail Ventures Ltd are among the other losers in the BSE’s ‘B’ group today, 10 March 2026.

Hindustan Oil Exploration Company Ltd, Dhruv Consultancy Services Ltd, Antelopus Selan Energy Ltd and JHS Svendgaard Retail Ventures Ltd are among the other losers in the BSE’s ‘B’ group today, 10 March 2026.

Orchasp Ltd lost 10.39% to Rs 2.07 at 14:30 IST.The stock was the biggest loser in the BSE’s ‘B’ group.On the BSE, 7.37 lakh shares were traded on the counter so far as against the average daily volumes of 1.04 lakh shares in the past one month.

 

Hindustan Oil Exploration Company Ltd crashed 10.05% to Rs 148.5. The stock was the second biggest loser in ‘B’ group.On the BSE, 1.47 lakh shares were traded on the counter so far as against the average daily volumes of 66636 shares in the past one month.

Dhruv Consultancy Services Ltd tumbled 8.88% to Rs 30.07. The stock was the third biggest loser in ‘B’ group.On the BSE, 1216 shares were traded on the counter so far as against the average daily volumes of 12909 shares in the past one month.

Antelopus Selan Energy Ltd corrected 8.78% to Rs 580. The stock was the fourth biggest loser in ‘B’ group.On the BSE, 21221 shares were traded on the counter so far as against the average daily volumes of 20679 shares in the past one month.

JHS Svendgaard Retail Ventures Ltd shed 7.91% to Rs 20.26. The stock was the fifth biggest loser in ‘B’ group.On the BSE, 133 shares were traded on the counter so far as against the average daily volumes of 698 shares in the past one month.

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Mar 10 2026 | 3:16 PM IST



Source link

Orchasp Ltd leads losers in 'B' group

Happiest Minds soars after lifting FY27 growth forecast amid AI demand


Happiest Minds Technologies surged 15.76% to Rs 393.76 after the company raised its FY27 growth projection to 12.5% up from earlier estimate of 10%, supported by its Artificial Intelligence (AI) -led initiatives and robust demand across sectors.

On February 10, 2026, the company launched AI First, its 11th Strategic Initiative. This initiative represents not merely an addition to the existing framework, but a strategic elevation: AI First reorients the company’s entire operating model, service delivery architecture, client engagement and value-creation mechanism.

At the time of the AI First launch, the company communicated that it was witnessing rapid acceptance of its initiatives across the client base. Acknowledging the pace of change the company had indicated it would undertake an evaluation of client feedback, pipeline metrics, market opportunities, and the expanded scope of its AI First offerings and providing an updated growth outlook.

 

Following this review, the company has revised its FY27 growth guidance upward to 12.5%. In exchange filing, the company said that it also believes this growth will establish a solid foundation for FY28, where it aspires to achieve 15% growth.

Ashok Soota, chairman & chief mentor, Happiest Minds, said, “Happiest Minds is witnessing an accelerated growth driven by AI and other strategic initiatives. We are leading from the front with our AI-First strategy, which is already delivering measurable results and driving client transformations at scale. With this momentum, we are strongly positioned for sustained leadership in the AI-driven future of IT services

Joseph Anantharaju, co-chairman & CEO, Happiest Minds, said, We are witnessing all-round growth led by rapid acceleration in financial services, healthcare, hi-tech, and manufacturing by robust adoption of AI. The enhanced pipeline and strong business momentum we are experiencing validates our AI First strategy and reinforces our confidence in delivering superior outcomes for clients and stakeholders. Our solid FY27 forecast is a clear reflection of this trajectory.

Happiest Minds Technologies enables digital transformation for enterprises and technology providers by delivering seamless customer experiences, business efficiency, and actionable insights.

The company has reported 25.4% fall in consolidated net profit to Rs 40.30 crore despite a 2.4% increase in revenues to Rs 587.56 crore in Q3 FY26 as compared with Q2 FY26.

Powered by Capital Market – Live News



Source link

Orchasp Ltd leads losers in 'B' group

Airtel expands its network to Marwah region in Jammu & Kashmir


Bharti Airtel announced the expansion of its network footprint to Marwah – a geographically remote area linking Kishtwar and Anantnag in Jammu & Kashmir. With this milestone deployment, Airtel has become the first and only service provider to deliver reliable mobile connectivity to this strategically significant and difficult-to-reach region.

Marwah, characterized by its rugged terrain and limited seasonal road access to Kishtwar and Anantnag, remains disconnected during winters due to heavy snow fall. This isolation forces residents to rely on mules or foot travel for essential supplies, work, or emergencies, while the absence of telecom coverage left approximately 150-km corridor disconnected. Airtel’s high-speed network rollout in this area marks a transformative step, empowering residents, security forces, and tourists with seamless connectivity in one of the India’s most challenging terrains.

 

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Mar 10 2026 | 1:50 PM IST



Source link

Orchasp Ltd leads losers in 'B' group

Jagsonpal Pharma sizzles as board to mull buyback proposal


Jagsonpal Pharmaceuticals surged 10.19% to Rs 187 after the company’s board is scheduled to meet on Thursday, 12 March 2026 to consider buyback of its fully paid up equity shares.

As on 31st December 2025, the companys promoter shareholding stood at 67.39%.

Jagsonpal Pharmaceuticals has portfolio of drugs focusing on gynaecology, orthopaedics, dermatology and child-care segments.

The companys standalone net profit fell 8.4% to Rs 12.49 crore on 1.5% fall in net sales to Rs 72.95 crore in Q3 FY26 compared with Q3 FY25.

Powered by Capital Market – Live News

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Mar 10 2026 | 12:04 PM IST



Source link

YouTube
Instagram
WhatsApp